ZHBIO(SZ:300653)2025-09-09 01:02Group 1: Market Performance and Competition - The company has successfully won bids for its meninges series products in all provinces where centralized procurement has been implemented, leading to a decrease in prices but an increase in sales volume, maintaining market share stability [3]. - The oral repair membrane products face intensified competition in the private market, with a price war becoming increasingly fierce; the company aims to solidify its market position through targeted strategies and collaboration with key terminals [4]. Group 2: Product Development and Innovations - The calcium silicate bioceramic bone repair material, expected to be registered by the end of 2025, features a porous structure similar to autologous bone, promoting bone regeneration and differentiation [4]. - The active biological bone product's promotion and hospital admission are progressing as planned, with no current impact from centralized procurement policies; the company is monitoring potential future policy changes [4]. Group 3: Future Plans and Strategic Initiatives - The company is exploring international market opportunities for some of its products and is in the planning stages for overseas expansion [4]. - A stock incentive plan is being developed in accordance with relevant regulations and the company's operational status, with updates to be disclosed in future announcements [4].